These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 58752)

  • 1. [New heparinoid extract in the treatment of arterial diseases of the lower limb].
    Caramelli L; Spinelli P
    Clin Ter; 1975 Oct; 75(1):43-63. PubMed ID: 58752
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of pentoxifylline (BL 191) in the treatment of peripheral blood circulation disorders].
    Cavaller JM; Samper JC
    Med Monatsschr; 1976 Jul; 30(7):323-6. PubMed ID: 790140
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nicotinyl in the treatment of arteriosclerosis obliterans of the lower limbs].
    Grodzińska L; Basista M; Byrska-Danek A; Kostka-Trabka E
    Pol Tyg Lek; 1984 Jun 12-25; 39(25-26):879-81. PubMed ID: 6387654
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diprophyllinum prolongatum (Polfa, Cracow) in the treatment of arteriosclerosis obliterans of the lower limbs].
    Kostka-Trabka E; Grodzińska L; Dembińska-Kieć A; Basista M; Telesz E
    Przegl Lek; 1983; 40(7):563-6. PubMed ID: 6356236
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
    Bagliani A; Borri P; Parravicini R
    Minerva Cardioangiol; 1975 Nov; 23(11):701-10. PubMed ID: 1223674
    [No Abstract]   [Full Text] [Related]  

  • 6. [Piribedil (TF 871) in the treatment of arteriopathies of the lower extremities].
    Argenteri A; Moia R; Negri L
    Ann Ital Chir; 1979; 51(2):145-55. PubMed ID: 554489
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prostacyclin in treatment of peripheral vascular disease of lower extremities (author's transl)].
    Szczeklik A; Głusko P; Gryglewski R; Szczeklik J; Kostka-Trabka E; Grodzińska L; Nizanowski R; Dembińska-Kieć A; Skawiński S; Bieroń K; Billewicz O; Telesz E
    Przegl Lek; 1980; 37(9):659-62. PubMed ID: 6106960
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of Sadamin on some blood clotting parameters and fibrinolysis in patients with obliterative arteriosclerosis of lower limb arteries].
    Kiersnowska B; Bielawiec M; Lukjan H; Korfel B; Rogowski F; Dowzyk W
    Pol Tyg Lek; 1973 Mar; 28(11):400-3. PubMed ID: 4694796
    [No Abstract]   [Full Text] [Related]  

  • 9. Levodopa in the treatment of arterial insufficiency of the lower limbs. Clinical and rheographic trial.
    Vaccaro E; Solitro A; Barba C
    Arzneimittelforschung; 1973 Dec; 23(12):1793-8. PubMed ID: 4205907
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of a fribrinolytic drug in an experimental cross-over study].
    Bizzi B; Butti A
    Minerva Med; 1969 Dec; 60(99 Suppl):5062-7. PubMed ID: 4188590
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum lipid levels in patients with arteriosclerosis obliterans of the legs during treatment with pentoxifylline].
    Kuczyńska K; Zebrowski M; Kancelarczyk WL; Rymaszewski Z
    Pol Tyg Lek; 1988 Aug; 43(34):1092-4. PubMed ID: 3075031
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clearing and anti-platelet-aggregation effects of a heparinoid of natural origin].
    Marini U; Bastoni F; Gibelli A
    Clin Ter; 1974 Oct; 71(1):13-31. PubMed ID: 4138995
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dalargin in the treatment of arteriosclerosis obliterans of the lower extremities].
    Dudko VA; Fedorova NA; Didenko VA; Zoloev GK
    Sov Med; 1990; (2):90-2. PubMed ID: 2192476
    [No Abstract]   [Full Text] [Related]  

  • 14. [Late results of the pyridinolcarbamate treatment of thrombotic obliterating arterial diseases of the extremities].
    Fisanovich TI; Tolstova LG
    Khirurgiia (Mosk); 1979 Sep; (9):76-80. PubMed ID: 502312
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic acquisitions on chronic obliterating peripheral arterial diseases of the lower limbs].
    Guagliano G; Bagliani A; Borri P
    Minerva Med; 1976 May; 67(25):1648-55. PubMed ID: 778666
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ozone therapy, a new method of treating chronic obliterating arteriopathies].
    Ionescu G; Pitea P; Blaj A
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(3):207-13. PubMed ID: 2931752
    [No Abstract]   [Full Text] [Related]  

  • 17. Results of a clinical trial with a new gel--association of a flavonoid and a heparinoid--in sports injuries.
    Lisý Z; Vrbicky B
    Schweiz Z Sportmed; 1988 Jun; 36(2):91-3. PubMed ID: 2456611
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of buflomedil in the treatment of obliterative arteriopathies of the lower extremities. Clinical and functional study].
    Cospite M; Ferrara F; Milio G; Meli F
    Clin Ter; 1984 Apr; 109(2):127-35. PubMed ID: 6234122
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic effects of nitrendipine (Bayotensin) in patients with arteriosclerosis obliterans of lower limbs.
    Grodzińska L; Basista M; Ohlrogge R
    Prog Clin Biol Res; 1989; 301():423-7. PubMed ID: 2678132
    [No Abstract]   [Full Text] [Related]  

  • 20. [Controlled clinical trial of a topical heparin- and heparinoid- based cream in the treatment of vascular diseases].
    Ghiringhelli L
    Boll Chim Farm; 1984 Apr; 123(4):42S-46S. PubMed ID: 6206879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.